Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-21-001079
Accepted
2021-03-24 00:15:20
Documents
1
Effectiveness Date
2021-03-23
Registration Form
S-4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 593
  Complete submission text file 9999999995-21-001079.txt   1838
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-252181 | Film No.: 21766461
SIC: 2835 In Vitro & In Vivo Diagnostic Substances